The global scleral lens market size was valued at USD 327.04 billion in 2024 and is expected to surpass around USD 982.68 billion by 2034, growing at a CAGR of 11.63%.
Get a Free Sample Copy of the Report@ https://www.precedenceresearch.com/sample/5807
Scleral Lens Market Key Points
-
The North American market led with 41% share in 2024, indicating strong regional demand.
-
Asia Pacific is projected to offer the highest return on investment through 2034.
-
Dominance of corneo-scleral and semi-scleral lenses reflects current consumer preference.
-
Mini-scleral lenses are a key area for future portfolio diversification.
-
Irregular cornea remains the top clinical driver of lens adoption.
-
Ocular surface disease presents a growing segment for expansion.
-
Eye clinics hold a leadership role in end-user revenue.
-
Hospitals represent an emerging growth vertical for lens manufacturers.
AI’s Growing Impact on Scleral Lens Innovation
AI is revolutionizing the scleral lens market by enhancing diagnostic precision and streamlining the lens fitting process. Advanced AI-powered imaging tools, such as topography and tomography systems, enable detailed mapping of the corneal and scleral surfaces. This data is processed using machine learning algorithms to recommend custom lens designs tailored to each patient’s unique eye anatomy. As a result, practitioners can achieve better fit accuracy, reduce trial-and-error fittings, and improve patient comfort and outcomes.
Additionally, AI is being integrated into tele-optometry and remote patient monitoring solutions. With AI-assisted diagnostics and digital health platforms, eye care providers can monitor lens performance, track patient compliance, and detect complications such as hypoxia or lens fogging in real-time. These innovations not only enhance clinical efficiency but also expand access to specialty lenses in underserved or remote regions, contributing to the overall growth of the scleral lens market.
Market Overview
The scleral lens market is steadily expanding due to its effectiveness in treating complex corneal and ocular surface conditions such as keratoconus, dry eye syndrome, and post-surgical corneal irregularities. These lenses are designed to vault over the cornea and rest on the sclera, creating a fluid-filled chamber that promotes healing and provides clear, stable vision. As more eye care professionals recommend these lenses for therapeutic and visual correction purposes, the demand continues to grow across both developed and emerging markets.
Market Scope
Report Coverage | Details |
Market Size by 2034 | USD 982.68 Billion |
Market Size in 2025 | USD 365.07 Billion |
Market Size in 2024 | USD 327.04 Billion |
Market Growth Rate from 2025 to 2034 | CAGR of 11.63% |
Dominated Region | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2024 |
Forecast Period | 2025 to 2034 |
Segments Covered | Type, Application, End User, and Regions |
Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Market Dynamics
Market Drivers
The market is primarily driven by the increasing prevalence of eye disorders and advancements in contact lens materials and fitting technologies. An aging global population and the rising incidence of vision problems caused by screen time and environmental factors are contributing to demand. Moreover, the growing number of optometrists and eye clinics trained in specialty lens fitting is improving access for patients in need of customized solutions.
Market Opportunities
There is significant opportunity in emerging markets where access to advanced vision care is improving. The integration of AI and digital imaging in scleral lens fitting is enhancing precision and patient comfort, making the lenses more accessible and appealing. Additionally, partnerships between manufacturers and healthcare providers to increase awareness and availability of scleral lenses in underserved regions present growth potential.
Market Challenges
Despite their benefits, the high cost of scleral lenses and the complex fitting process remain major challenges. These lenses often require multiple appointments for proper fitting, which can be time-consuming and expensive. Limited insurance coverage and a shortage of trained professionals in rural or underdeveloped areas also hinder widespread adoption.
Regional Insights
North America dominated the global scleral lens market in 2024, benefiting from a strong healthcare system, high awareness, and access to specialized eye care. Asia Pacific is expected to witness the fastest growth during the forecast period, supported by expanding healthcare infrastructure and increasing investment in ophthalmology. Europe is also seeing consistent growth, particularly in countries where specialty contact lenses are gaining acceptance in public and private healthcare settings.
Scleral Lens Market Companies

- ABB Optical Group
- Alden Optical Laboratories
- Art Optical Contact Lens Inc.
- Bausch Health Companies Inc.
- Blanchard Lab
- Boston Sight
- Essilor
- SynergEyes
- TruForm Optics Inc.
- Valley Contax
- Visionary Optics
Latest Announcements by Market Leaders
- In February 2025, ABB Optical Group announced the launch of the Delta Scleral, the next generation of scleral contact lenses, which premiered at GSLS 2025. ABB also announced the launch of HydroPure MPS and HydroPure Lubricating Eye Drops for both soft and gas-permeable lenses. HydroPure is an exclusive product line for ECPs through ABB Optical Group.
- In February 2023, Visionary Optics announced the launch of Europa Tangent, a new scleral lens that provides a customizable design and a three-zone step system for optimal fitting; according to the release, the lens design was based on clinical experience and analysis of data from more than 10,000 fittings.
Recent Developments
- In May 2024, Bausch + Lomb Corporation announced the U.S. launch of Zenlens ECHO, a non-prosthetic, custom scleral contact lens technology designed to fit a wide variety of corneal shapes and sizes, including patients who have advanced ocular conditions such as corneal degeneration and certain postoperative conditions.
- In February 2023, Visionary Optics launched Europa Tangent, a new scleral lens that provides a customizable design and a three-zone step system for optimal fitting. The lens design was based on clinical experience and analysis of data from more than 10,000 fittings.
Segments Covered in the Report
By Type
- Corneo-Scleral Lenses and Semi-Scleral Lenses
- Mini-Scleral Lenses
- Full Scleral Lenses
By Application
- Irregular Cornea
- Ocular Surface Disease
- Refractive Error
- Other Applications
By End-User
- Hospitals
- Eye Clinics
- Other End Users
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Also Read: Water for Injection Market
Ready for more? Dive into the full experience on our website@ https://www.precedenceresearch.com/